NASDAQ · Medical - Devices

SINT (SINT) Stock

$1.70 +12.58% NASDAQ: SINT Healthcare

Valuation

MetricValue
Price$1.70
Market Cap$4.72M
P/E Ratio-1.55
P/B Ratio10.14
P/S Ratio5.96
EPS (TTM)$-1.75
52-Week High$6.78
52-Week Low$1.40
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-311.41%
ROA-73.90%
ROCE-366.67%
Gross Margin-32.65%
Operating Margin-11.22%
Net Margin-17.12%
Debt/Equity3.49
Current Ratio1.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$3.0M$1.0M$1.0M
Operating Profit$-11.0M$-11.0M$-13.0M$-14.0M$-11.0M
Net Profit$-9.0M$-12.0M$-8.0M$-11.0M$-17.0M
EPS$-39.75$-51.96$-19.42$-15.19$-6.16
Op Margin-1752.5%-1886.0%-508.5%-1127.4%-1053.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$22.0M$16.0M$15.0M$9.0M$10.0M
Total Liabilities$5.0M$10.0M$7.0M$6.0M$7.0M
Cash$14.0M$6.0M$3.0M$4.0M$4.0M
Borrowings$3.0M$4.0M$5.0M$4.0M$3.0M

Latest News

Sintx Technologies Receives Over $3.2 Million in Advanced Ceramic Purchase Orders MT Newswires · Jun 22, 2026 SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders GlobeNewswire · Jun 22, 2026 Sintx Technologies Insiders Placed Bullish Bets Worth US$644.2k Simply Wall St. · Jun 12, 2026 SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules GlobeNewswire · Jun 3, 2026 SINTX Technologies to Present at the LD Micro Invitational XVI Conference TMX Newsfile · May 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-10.0M$-10.0M$-14.0M$-9.0M$-9.0M
Investing Cash Flow$-5.0M$-3.0M$-1.0M$-1.0M$1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-11.0M$-8.0M$-3.0M$0$1.0M
Free Cash Flow$-14.0M$-12.0M$-15.0M$-9.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA-0.95
FCF Yield-161.33%
Quick Ratio0.70
Interest Coverage
Return 1Y-43.53%
Return 3Y-99.46%
Return 5Y-99.99%

Ownership

Insiders Held34.16%
Institutions Held10.01%
Institutions Float Held15.20%
Institutional HolderSharesReport Date
Veracity Capital LLC76,6742026-06-30
Geode Capital Management, LLC32,1442026-03-31
Vanguard Fiduciary Trust Co23,5312026-03-31
Vanguard Capital Management LLC20,9052026-03-31
Xtx Topco Ltd17,0482026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DHAIDIH Holding US, Inc. $0.02 +0.00% 0.00 $41853 0.00%
HSCS $2.18 +4.81% -0.70 $4.71M 0.00%
IINNInspira Technologies OXY B.H.N. Ltd. $1.26 -5.97% -2.80 $30.34M 0.00%
LFWD $7.00 -1.41% -0.39 $11.28M 0.00%
PFSAProfusa, Inc. Common Stock $1.03 -39.77% -0.01 $22940 0.00%

About SINT

SINT is led by CEO Eric K. Olson, employs 20 people, headquartered in US, publicly traded since 2014.

SINT stock trades at $1.70 with a market capitalization of $4.72M. The stock is valued at a price-to-earnings (P/E) ratio of -1.55, price-to-book of 10.14, price-to-sales of 5.96. Over the past 52 weeks the stock has ranged between $1.40 and $6.78, and currently trades 74.9% below its 52-week high.

On profitability, SINT generates a return on equity (ROE) of -311.41%, return on capital employed of -366.67%, an operating margin of -11.22%, a net profit margin of -17.12%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides